STRATEGY FOR THE USE OF ERYTHROPOETIN ALPHA TO MAINTAIN HEMOGLOBIN LEVEL IN BREAST CANCER PATIENT TREATED WITH ANTHRACYCLINE-BASE OF ADJUVANT CHEMOTHERAPY

STRATEGY FOR THE USE OF ERYTHROPOETIN ALPHA TO MAINTAIN HEMOGLOBIN LEVEL IN BREAST CANCER PATIENT TREATED WITH ANTHRACYCLINE-BASE OF ADJUVANT CHEMOTHERAPY

Objective: To evaluate the value of erythropoietin alpha (epoetin) administration, as an alternative treatment of anemia in the operable breast cancer patients. Methods: This is a multicenter phase III randomized clinical trial to evaluate the value of epoetin administration among anemic breast c...

Full description

Bibliographic Details
Main Authors: Dimyati Achmad, Yusuf Hariady, Benny Isakh, Maman Abdurrahman, Ahmad Faried
Format: Article
Language:English
Published: Universitas Padjadjaran 2015-07-01
Series:International Journal of Integrated Health Sciences
Subjects:
Anthracyclin-based chemotherapy
breast cancer
erythropoietin alpha
Online Access:http://journal.fk.unpad.ac.id/index.php/ijihs/article/view/102/88

Internet

http://journal.fk.unpad.ac.id/index.php/ijihs/article/view/102/88

Similar Items